Paperdoi:10.1161/circ.154.suppl_1.10098

Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098)

Venue listed2026Added Nov 15, 2026

  • MV
  • VT
  • KK
  • AR

Authors: Miska Valkonen, Venla Timisjarvi, Kianoosh Kazemi, Aleksi Rantanen

Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098 (2026-11-02)

TL;DR

Proprietary cuffless PPG estimated MAP (eMAP) on 90,465 Oura Ring users over 30 days (mean age 42.7, 70.5% female). Each night's sleep-vs-day eMAP change classed extreme (< −20%), normal (−20 to −10%), non-dipper (−10 to 0%), reverse (> 0%); modal class = phenotype. Result: 15.2% extreme, 66.7% normal, 17.7% non-dipper, 0.4% reverse (18.1% abnormal); abnormal dipping rose from 13.4% (< 30 y) to 48.5% (≥ 70 y).

  • Form factor: finger (Oura ring)

Abstract

Background: Nocturnal blood pressure (BP) non-dipping is an emerging independent predictor of cardiovascular events and mortality. However, population-level prevalence remains poorly characterized, as ambulatory blood pressure monitoring (ABPM) — the gold standard method for out-of-clinic blood pressure assessment — is rarely conducted at scale. Here, we applied a cuffless PPG-based blood pressure method to a large consumer wearable cohort to estimate nocturnal dipping prevalence and its clinical correlates.

Methods: We retrospectively analysed deidentified data from 90,465 adult Oura Ring users with PPG monitoring across a 30-day window (mean age 42.7 ± 12.8 years; 70.5% female; BMI 27.2 ± 5.7 kg/m 2 ). Estimated MAP (eMAP) was derived from a proprietary cuffless PPG algorithm. For each night, sleep-vs-daytime eMAP percentage change was assigned to one of four classes — extreme (0%). Each user's modal class across available nights served as their dipping phenotype, with non-dipper and reverse classified as abnormal. Associations with self-reported cardiovascular and metabolic diagnoses were tested with χ 2 , Cochran-Armitage trend, and multivariable logistic regression adjusted for age, sex, and BMI. The eMAP algorithm was previously validated against simultaneous 48-hour Oscar2 ABPM in 134 adults, with dipper-vs-non-dipper AUC 0.87 at the 10% threshold and mean absolute error 5.41 mmHg for nocturnal eMAP change.

Results: Overall, 15.2% of users were extreme, 66.7% normal, 17.7% non-dipper, and 0.4% reverse dippers (18.1% abnormal). Abnormal dipping rose monotonically with age, from 13.4% at 2 = 1584, p 2 BMI (1.05, 1.04-1.05). Obstructive sleep apnea was associated in unadjusted analyses (OSA+ 24.3% vs OSA– 17.4% abnormal) but attenuated to near-null after adjustment (aOR 0.94, 0.88-0.99), indicating the unadjusted association was largely explained by confounding with age, BMI, and hypertension.

Conclusions: Cuffless wearable PPG identifies abnormal nocturnal BP dipping in 18.1% of the sample, rising with age and tracking established cardiometabolic risk factors. Modal-class phenotyping over many nights provides a scalable approach for population-level surveillance and risk stratification, motivating prospective validation against ABPM in outcome-linked cohorts.

Verbatim from the publisher's DOI record (opens in a new tab) · Abstract as deposited by the publisher with Crossref; © the authors/publisher

Results on ChatPPG leaderboards

All leaderboards

No results from this paper on ChatPPG leaderboards yet. Browse the leaderboards.

Tasks & signals

Tasks

Blood pressure

Signals

Keywords

Cuffless BPBP TrendsNocturnal DippingOuraPopulation ScaleConference Abstract

How it works

How Method works: Setup → Method → TargetSetup: Signals (PPG); Form factor (finger (Oura ring)). Method: Method. Target: Blood pressure.SetupSignals: PPGSignalsPPGForm factor: finger (Oura ring)Form factorfinger (Oura ring)MethodMethodTargetBlood pressureBlood pressure

Cite this paper

Cite this paper with the fields recorded here. Check it against the publisher before submitting.

Valkonen, M., Timisjarvi, V., Kazemi, K., & Rantanen, A. (2026). Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098). Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098. https://doi.org/10.1161/circ.154.suppl_1.10098
Valkonen, Miska, Venla Timisjarvi, Kianoosh Kazemi, and Aleksi Rantanen. 2026. "Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098)." Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098. https://doi.org/10.1161/circ.154.suppl_1.10098.
Valkonen, M., Timisjarvi, V., Kazemi, K. and Rantanen, A. (2026) 'Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098)', Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098. doi: 10.1161/circ.154.suppl_1.10098.
Valkonen, Miska, et al. "Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098)." Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098, 2026. https://doi.org/10.1161/circ.154.suppl_1.10098.
M. Valkonen, V. Timisjarvi, K. Kazemi, and A. Rantanen, "Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098)," Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098, 2026, doi: 10.1161/circ.154.suppl_1.10098.
@article{valkonen2026populationlevel,
  title         = {{Population-Level Prevalence of Nocturnal Blood Pressure Dipping Phenotypes: Insights from 90,465 Oura Ring Users (AHA 2026 Abstract 10098)}},
  author        = {Valkonen, Miska and Timisjarvi, Venla and Kazemi, Kianoosh and Rantanen, Aleksi},
  year          = {2026},
  journal       = {Circulation 154 suppl 1, AHA Scientific Sessions 2026, Abstract 10098},
  doi           = {10.1161/circ.154.suppl_1.10098}
}

Added to the ChatPPG research hub